Attovia Therapeutics annual shares outstanding
2024
2025
Attovia Therapeutics Shares Outstanding History (ATTO)
Attovia Therapeutics reported 4.5M shares outstanding at the end of fiscal 2025.
View full Attovia Therapeutics company overviewAttovia Therapeutics annual shares outstanding history
| Fiscal year | Period ended | Shares outstanding | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | 4.5M | −38.5M | −89.53% |
| 2024 | 2024-12-31 | 43.0M | — | — |
Attovia Therapeutics quarterly shares outstanding
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Shares outstanding | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | 4.5M | — | — |
| Q1 2026 | 2026-03-31 | 43.0M | — | — |
| Q4 2025 | 2025-12-31 | 4.5M | — | — |
Attovia Therapeutics shares outstanding trends
Between the periods ended 2024-12-31 and 2025-12-31, Attovia Therapeutics's shares outstanding moved from 43.0M to 4.5M, a change of −38.5M. The latest reported quarter, Q2 2026, shows 4.5M.
About the metric
What shares outstanding means
Shares outstanding is the number of common shares held by investors at a reporting-period end. The count can change because of stock issuance, repurchases, conversions, acquisitions, or stock splits.
Calculation and source
SEC-reported period-end shares
TickerStat displays period-end common shares from SEC filings and adjusts older values to the current share basis when a stock-split conversion ratio is reported directly or evidenced by a later filing’s restated historical share balance. After repeated reverse splits, an old period can represent less than one current-basis share; this is a split-adjusted equivalent, not a literal historical certificate count. Values remain as reported when no reliable split ratio is available. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Attovia Therapeutics source filings ↗